Puma Biotechnology Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Revenue	230.47	235.64	228.03	253.16	225.11	Upgrade
Revenue Growth (YoY)	-2.19%	3.34%	-9.92%	12.46%	-17.32%	Upgrade
Cost of Revenue	64.4	62.68	55.09	63.7	39.37	Upgrade
Gross Profit	166.06	172.96	172.94	189.45	185.74	Upgrade
Selling, General & Admin	80.16	89.31	89.98	116.29	118.49	Upgrade
Research & Development	54.94	50.38	52.24	71.87	97.65	Upgrade
Operating Expenses	135.1	139.69	142.22	188.16	216.14	Upgrade
Operating Income	30.97	33.27	30.72	1.29	-30.4	Upgrade
Interest Expense	-12.45	-13.33	-11.59	-12.81	-14.05	Upgrade
Interest & Investment Income	4.72	2.61	0.81	0.16	0.49	Upgrade
Other Non Operating Income (Expenses)	0.86	0.76	-0.03	0.29	0.37	Upgrade
EBT Excluding Unusual Items	24.1	23.3	19.91	-11.07	-43.59	Upgrade
Asset Writedown	-	-0.63	-	-	-	Upgrade
Legal Settlements	-	-	-12.46	-9.59	-16.2	Upgrade
Other Unusual Items	-	-	-	-8.15	-	Upgrade
Pretax Income	24.1	22.67	0.46	-28.8	-59.79	Upgrade
Income Tax Expense	-6.18	1.08	0.46	0.32	0.21	Upgrade
Net Income	30.28	21.59	0	-29.13	-60	Upgrade
Net Income to Common	30.28	21.59	0	-29.13	-60	Upgrade
Net Income Growth	40.23%	1079450.00%	-	-	-	Upgrade
Shares Outstanding (Basic)	49	47	45	41	40	Upgrade
Shares Outstanding (Diluted)	49	48	45	41	40	Upgrade
Shares Change (YoY)	3.26%	5.83%	10.56%	2.69%	2.08%	Upgrade
EPS (Basic)	0.62	0.46	0.00	-0.72	-1.52	Upgrade
EPS (Diluted)	0.62	0.45	0.00	-0.72	-1.52	Upgrade
EPS Growth	37.78%	1022625.00%	-	-	-	Upgrade
Free Cash Flow	38.86	26.87	-15.83	20.65	0.73	Upgrade
Free Cash Flow Per Share	0.79	0.56	-0.35	0.51	0.02	Upgrade
Gross Margin	72.06%	73.40%	75.84%	74.84%	82.51%	Upgrade
Operating Margin	13.44%	14.12%	13.47%	0.51%	-13.51%	Upgrade
Profit Margin	13.14%	9.16%	0.00%	-11.51%	-26.65%	Upgrade
Free Cash Flow Margin	16.86%	11.40%	-6.94%	8.16%	0.32%	Upgrade
EBITDA	42.49	44.78	40.56	12.6	-20.37	Upgrade
EBITDA Margin	18.44%	19.01%	17.79%	4.98%	-9.05%	Upgrade
D&A For EBITDA	11.52	11.52	9.84	11.31	10.03	Upgrade
EBIT	30.97	33.27	30.72	1.29	-30.4	Upgrade
EBIT Margin	13.44%	14.12%	13.47%	0.51%	-13.51%	Upgrade
Effective Tax Rate	-	4.78%	99.56%	-	-	Upgrade
Revenue as Reported	230.47	235.64	228.03	253.16	225.11	Upgrade

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q